A UCSF-led study examining the impact of statins on the progression of multiple sclerosis found a lower incidence of new brain lesions in patients taking the cholesterol-lowering drug in the early ...
SALT LAKE CITY – An international team of researchers has found that adding a humanized monoclonal antibody called daclizumab to standard treatment reduces the number of new or enlarged brain lesions ...
The leading conference for multiple sclerosis health care professionals, the 2014 Cooperative Meeting of CMSC (Consortium of Multiple Sclerosis Centers) & ACTRIMS® (Americas Committee for Treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results